Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioProtect
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Males
At lease 18 years of age
Undergoing external beam or brachy radiation therapy with a hydrogel spacer
You may not be if
Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension
Clareo Health | Prospective Evaluation of a Commercially Available Hydrogel Spacer
